Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Tremelimumab (Primary)
- Indications Bladder cancer; Ureteral neoplasms; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- 31 Jan 2019 Status changed from not yet recruiting to recruiting.
- 03 Oct 2018 Planned initiation date changed from 1 Jul 2018 to 1 Nov 2018.
- 21 Jun 2018 New trial record